// App-Quantinova.ai

11001 : Efficacy of busulfan-melphalan high dose chemotherapy consolidation (BuMel) compared to conventional chemotherapy combined with lung irradiation in ewing sarcoma (ES) with primary lung metastases: Results of EURO-EWING 99-R2pulm randomized trial (EE99R2pul).

Researchers

Presenter

  • Uta Dirksen

Principal Investigators

  • Bernadette Brennan

  • Ian Robert Judson

  • Mark L. Bernstein

  • Richard Greg Gorlick

  • Neyssa Marina

  • Richard B. Womer

  • Nathalie Cozic

  • Nathalie Gaspar

  • Gwenael Le Teuff

  • Perrine Marec-Berard

  • Andreas Faldum

  • Michael Paulussen

  • Herbert Juergens

  • Lars Hjorth

  • Keith Wheatley

  • Mark D. Krailo

  • Jeremy Whelan

  • Douglas S. Hawkins

Medical Centers

  • Westfalische Wilhelms-Universitat Munster, Munster, Germany

  • Department of Biostatistics and Epidemiology, Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France

  • Royal Manchester Children's Hospital, Manchester, United Kingdom

  • The Royal Marsden Hospital, London, United Kingdom

  • IWK Health Centre, Halifax, NS, Canada

  • The Children's Hospital, Bronx, NY

  • Stanford School of Medicine, Stanford, CA

  • Childrens Hospital of Philadelphia, Philadelphia, PA

  • Biostatistics Unit, Gustave Roussy Cancer Campus, Villejuif, France

  • Institut Gustave-Roussy, Villejuif, France

  • Department of Biostatistics and Epidemiology. Gustave Roussy Cancer Campus. Paris-Saclay University, Paris-Sud University, Villejuif, France

  • Institut d'Hematologie et d'Oncologie Pediatrie, Lyon, France

  • Institute of Biostatistics and Clinical Research, Westfalische Wilhelms-University Munster, Munster, Germany

  • Kinderklinik Datteln, Dattlen, Germany

  • Universitaetskinderklinik, Muenster, Germany

  • Lund University Hospital, Lund, Sweden

  • University of Birmingham, Birmingham, United Kingdom

  • Children's Oncology Group, Monrovia, CA

  • Kings College London, London, United Kingdom

  • Seattle Childrens Hospital, Seattle, WA

Locations

  • Canada

  • Germany

  • United Kingdom

  • United States

  • France

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solitary fibrous tumor

  • Ewing's sarcoma

  • Sarcoma

Biomarkers

  • N/A

Drug/Treatment

  • Vincristine

  • Doxorubicin

  • Ifosfamide

  • Etoposide

  • Etoposide phosphate

  • Melphalan

  • Busulfan

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved